Development
The Clorox Company
CLX
$122.17
$0.590.49%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.99B | 1.39B | 2.02B | 1.92B | 1.72B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.99B | 1.39B | 2.02B | 1.92B | 1.72B |
| Cost of Revenue | 1.12B | 843.00M | 1.16B | 1.12B | 1.10B |
| Gross Profit | 866.00M | 543.00M | 860.00M | 800.00M | 620.00M |
| SG&A Expenses | 510.00M | 433.00M | 543.00M | 515.00M | 438.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.00M | 7.00M | 25.00M | 5.00M | -5.00M |
| Total Operating Expenses | 1.66B | 1.31B | 1.77B | 1.67B | 1.56B |
| Operating Income | 327.00M | 74.00M | 253.00M | 245.00M | 154.00M |
| Income Before Tax | 136.00M | 29.00M | 237.00M | -245.00M | 130.00M |
| Income Tax Expenses | 40.00M | 4.00M | 56.00M | -36.00M | 28.00M |
| Earnings from Continuing Operations | 96.00M | 25.00M | 181.00M | -209.00M | 102.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.00M | -3.00M | -5.00M | -2.00M | -3.00M |
| Net Income | 93.00M | 22.00M | 176.00M | -211.00M | 99.00M |
| EBIT | 327.00M | 74.00M | 253.00M | 245.00M | 154.00M |
| EBITDA | 384.00M | 135.00M | 305.00M | 305.00M | 212.00M |
| EPS Basic | 0.75 | 0.18 | 1.42 | -1.71 | 0.80 |
| Normalized Basic EPS | 1.46 | 0.24 | 1.17 | 1.10 | 0.65 |
| EPS Diluted | 0.75 | 0.17 | 1.41 | -1.71 | 0.80 |
| Normalized Diluted EPS | 1.45 | 0.24 | 1.16 | 1.10 | 0.65 |
| Average Basic Shares Outstanding | 124.18M | 123.97M | 123.82M | 123.65M | 123.55M |
| Average Diluted Shares Outstanding | 124.62M | 124.65M | 124.64M | 123.65M | 123.99M |
| Dividend Per Share | 1.20 | 1.20 | 1.20 | 1.18 | 1.18 |
| Payout Ratio | 160.22% | 677.27% | 82.95% | -69.19% | 147.47% |